HomeALDX • NASDAQ
add
Aldeyra Therapeutics Inc
Previous close
$3.94
Day range
$3.73 - $3.99
Year range
$1.42 - $11.97
Market cap
223.99M USD
Avg Volume
677.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.39M | -44.10% |
Net income | -8.08M | 48.24% |
Net profit margin | — | — |
Earnings per share | -0.14 | 48.15% |
EBITDA | -9.33M | 44.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 83.04M | -49.68% |
Total assets | 141.30M | -16.00% |
Total liabilities | 27.88M | -9.99% |
Total equity | 113.42M | — |
Shares outstanding | 59.41M | — |
Price to book | 2.06 | — |
Return on assets | -16.22% | — |
Return on capital | -17.76% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -8.08M | 48.24% |
Cash from operations | -9.97M | -5.60% |
Cash from investing | -30.38M | -201.26% |
Cash from financing | 18.19K | -65.39% |
Net change in cash | -40.33M | -295.70% |
Free cash flow | -58.04M | -2,593.71% |
About
Founded
2004
Headquarters
Website
Employees
10